• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Patient Monitoring

Glucotrack to effect a reverse stock split

June 13, 2025 By Sean Whooley

GlucoTrack updated Logo (1)

Glucotrack (Nasdaq:GCTK) announced that it plans to effect a 1-for-60 reverse stock split of its issued and outstanding common stock. Rutherford, New Jersey-based Glucotrack — maker of a long-term implantable continuous blood glucose monitor (CBGM) — intends for the split to go into effect when the market opens on Monday, June 16, 2025. Under the terms […]

Filed Under: Business/Financial News, Diabetes, Implants, Patient Monitoring, Technology, Wall Street Beat Tagged With: Glucotrack

Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit

June 12, 2025 By Sean Whooley

Medtronic Simplera Sync CGM with MiniMed 780G (1)

Medtronic (NYSE:MDT) announced today that it selected “MiniMed” as the name for its Diabetes unit following its planned separation. The medtech giant announced last month that it planned to separate the Diabetes unit. The move sought to create “a more focused Medtronic” with a more simplified portfolio in high-margin growth markets. At the same time, […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Medtronic, minimed

Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7

June 10, 2025 By Sean Whooley

Insulet Omnipod 5 with Dexcom G7

Insulet (Nasdaq:PODD) today announced the compatibility of its Omnipod 5 App for iPhone with Dexcom G7 continuous glucose monitor (CGM). The latest integration combines the benefits of the companies’ latest technologies, all conveniently controlled from an iPhone. Omnipod 5, the first FDA-cleared tubeless automated insulin delivery system, communicates with a CGM, such as G7. It […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom, Insulet

Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor

June 10, 2025 By Sean Whooley

Tandem Abbott Mobi FreeStyle Libre

Tandem Diabetes Care (Nasdaq:TNDM) today announced an agreement to develop and commercialize diabetes tech with Abbott (NYSE:ABT). San Diego–based Tandem said it agreed to combine its insulin delivery systems with Abbott’s future dual glucose-ketone sensor. The companies aim to provide more options for people to manage their diabetes. This marks the second recent collaboration announcement […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, Tandem Diabetes Care

Roche, IBM collab on predictive AI for CGM tech

June 9, 2025 By Sean Whooley

Roche Accu-Chek SmartGuide IBM Predict

Roche and IBM recently announced the development of an AI-enabled solution to predict glucose levels through continuous glucose monitors (CGMs). Together, the companies developed the AI-based Accu-Chek SmartGuide Predict app. They said in a news release that they launched the solution in Switzerland earlier this year. Roche first unveiled its Accu-Chek SmartGuide in an event at […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Roche, Roche Diabetes Care

Senseonics closes public offering, private placement with Abbott

May 22, 2025 By Sean Whooley

Senseonics logo

Senseonics (NYSE:SENS) announced that it closed its previously announced public offering and private placement with Abbott. Last week, the long-term continuous glucose monitor maker said it commenced an underwritten public offering of common stock worth $50 million. At the same time, it entered into a securities purchase agreement with another CGM maker — Abbott. Under […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Funding Roundup, Implants, Patient Monitoring, Technology Tagged With: Senseonics

Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor

May 22, 2025 By Sean Whooley

Abbott FreeStyle Libre 3 Plus Sequel Med Tech Twiist

Sequel Med Tech announced today that it agreed to integrate its twiist automated insulin delivery system with a future Abbott sensor. The companies agreed to pair twiist, powered by Tidepool, with Abbott‘s glucose-ketone sensor, currently under development. Sequel said the agreement aims to improve outcomes for people with type 1 diabetes. It adds ketone sensing capabilities […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, Sequel Med Tech

Medtronic to separate Diabetes business unit

May 21, 2025 By Sean Whooley

Medtronic Simplera Sync CGM with MiniMed 780G (1)

Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into a new standalone company. The medtech giant said the strategic decision can create “a more focused Medtronic” with a more simplified portfolio in high-margin growth markets. At the same time, it creates an independent, scaled leader in diabetes. The new company — […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Initial Public Offering (IPO), MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Medtronic

Senseonics opens $50M public offering, $25M private placement with Abbott

May 15, 2025 By Sean Whooley

Senseonics logo

Senseonics (NYSE:SENS) announced today that it commenced an underwritten public offering of common stock worth $50 million. The long-term implantable continuous glucose monitor (CGM) maker expects to grant underwriters a 30-day option to purchase up to an additional 15% of the total number of shares of stock offered in the public offering. All shares to be […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Implants, Patient Monitoring, Technology Tagged With: Senseonics

Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

May 15, 2025 By Sean Whooley

Abbott FreeStyle Libre linked with fewer hospitalizations from heart complications in people with diabetes (1)

Abbott (NYSE:ABT) today announced results from real-world studies demonstrating benefits with its FreeStyle Libre continuous glucose monitoring (CGM) technology. Results from the REFLECT studies show that Libre CGM is associated with a significant reduction in the risk of hospitalization for heart complications in people with diabetes. Data demonstrated that CGM can help lessen the severity […]

Filed Under: Cardiovascular, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 70
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS